The Netherlands established a national research and innovation center for long COVID and other post-acute infectious syndromes to accelerate the development of targeted treatment methods, as funding for research on the long-term effects of COVID-19 has exhausted available resources, and there was a risk that the loss of researchers would prolong the wait for new therapeutic approaches. (translated)







